I am an associate attending physicist in the Clinical Physics Service of the Department of Medical Physics. I lead a team within the External Beam Treatment Planning Section, which plans and supports treatments for head and neck and Central Nervous System cancers. My team has expertise in designing treatments that deliver high-dose stereotactic radiosurgery to the brain and paraspinal tumors, as well as supporting an innovative adaptive head and neck program. My research interests focus on automating processes in treatment planning, using imaging to design and adapt treatment, and quantitative image analysis for predictive modeling.
I received my PhD from the University of Chicago in 2008 and was board certified in therapeutic medical physics by the American Board of Radiology in 2013. I am a member of the American Association of Physicist in Medicine, the European Society for Radiotherapy and Oncology, and the American Society for Radiation Oncology.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Michalis Aristophanous discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures